Marc is the founder and owner of Advanced Investor Technologies, LLC, as well as the publisher and editor at the financial web site ChecktheMarkets.com. He holds an MS in Clinical Psychology from California Polytechnic State University and is a former senior vice president of investments for two major brokerage firms. Besides his role as an investment publisher and analyst, he serves as a marketing consultant to the investment publishing and investment media industries.
Twitter: Follow @m8a2r1
Google +: Marc Courtenay
Recent Articles By The Author
Travelers Buyback Bonanza Makes Its Stock an Undervalued Bargain
The insurance company's stock repurchase plan has been like an extra dividend for shareholders.
Is T-Mobile Stock a Prize or Should Investors Just Hang Up?
This major mobile carrier offers a share price too low for investors to ignore.
Discover Financial Services Is a Buy With Plenty of Upside
Shares of this purveyor of a range of financial products offer investors more upside than most realize
ConocoPhillips, Cut by Warren Buffett, Can Be Yours on the Rebound
Shares fell 9% during the quarter, which offers a compelling entry price now.
Walgreen Trails CVS in the In-Store Clinic Race to Keep You Healthy
CVS dominates with its 'MinuteClinics,' leaving Walgreen in its dust as both face increasing competition from Wal-Mart and Target.
Lockheed Martin’s Booming Business a Strong Defense for Investors
Shares of the world’s largest, most prolific defense contractor offer a rewarding total return based on sustainable payouts to investors.
Yahoo! Remains the Best Way to Play Alibaba IPO
Yahoo!'s stake in the Chinese Internet company isn't fully factored into the stock price.
Boeing Readies for Takeoff as Shares Appear to Hit Bottom
Shares are down 16% from Boeing's 52-week high offering a rare opportunity to buy this high-flier on sale.
Disney's Dizzyingly High Share Price Suggests a Break-Up May Be Coming
With new 52-week highs, the ebullient mega-media dynasty's share price may need a spinoff to unlock hidden value for investors.
Johnson & Johnson Can Only Get Better When It Gets Cheaper
Income investors are waiting for the health products company to revisit $94, bringing the dividend yield back up to 3%.